Want to see NNOX full AI Analyst Report?
NNOX Stock Chart & Stats
$1.72
-$0.69(-7.28%)
At close: 4:00 PM EST
$1.72
-$0.69(-7.28%)
Day’s Range― - ―
52-Week Range$0.73 - $5.69
Previous CloseN/A
Volume2.46M
Average Volume (3M)2.98M
Market Cap
$84.22M
Enterprise Value$79.09M
Total Cash (Recent Filing)$43.85M
Total Debt (Recent Filing)$7.64M
Price to Earnings (P/E)―
Beta1.66
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.14
Shares Outstanding69,600,784
10 Day Avg. Volume6,505,689
30 Day Avg. Volume2,975,336
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.30
Price to Sales (P/S)13.93
P/FCF Ratio-4.03
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue5.45
Enterprise Value/Gross Profit-6.36
Enterprise Value/Ebitda-1.59
Forecast
1Y Price Target
$5.00Price Target Upside190.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.63
Revenue Forecast (FY)$27.14M
Bulls Say, Bears Say
Bulls Say
Recurring Service-oriented Revenue ModelA service-first model (per-scan/subscription plus software/services) supports recurring revenue, higher customer lifetime value, and predictable utilization-driven cash flow as deployments scale. This structural model aligns incentives for usage growth and cross-sell of AI and IT services over years.
Low Financial LeverageVery low leverage gives the company financial flexibility to fund near-term deployment, R&D and restructuring without high interest burdens. This reduces bankruptcy pressure from fixed claims and provides room to raise capital or absorb temporary losses while commercial traction is pursued.
Large Partner Pipeline And Operational DeploymentsA multi-hundred unit partner pipeline and an operational RadNet reference site indicate commercial validation and distribution reach. If converted, partner-led deployments enable scale for recurring service fees and software cross-sales, strengthening long-term revenue base and barrier to entry through installed ecosystem.
Bears Say
Persistent Negative Gross Profit And LossesOngoing negative gross margins mean core offerings don't yet cover direct costs, preventing operating leverage. Even with revenue growth, sustained gross losses require structural cost reductions, pricing changes, or product improvements before the business can generate durable operating profits.
High Cash Burn And Weak Cash GenerationLarge and persistent negative OCF/FCF forces continual external financing, diluting shareholders and creating runway risk. Cash-intensive commercialization timelines and capex for deployments mean execution depends on capital markets access, making operational plans vulnerable if funding conditions tighten.
Guidance Withdrawal And Delayed Revenue RecognitionRemoving annual guidance and citing variable install-to-revenue timelines signals execution risk converting agreements into recognized sales. This structural uncertainty complicates capacity planning, cash-flow forecasting and investor confidence until conversion timing is consistently demonstrated.
Nano-X Imaging News
NNOX FAQ
What was Nano-X Imaging Ltd.’s price range in the past 12 months?
Nano-X Imaging Ltd. lowest stock price was $0.73 and its highest was $5.69 in the past 12 months.
What is Nano-X Imaging Ltd.’s market cap?
Nano-X Imaging Ltd.’s market cap is $84.22M.
When is Nano-X Imaging Ltd.’s upcoming earnings report date?
Nano-X Imaging Ltd.’s upcoming earnings report date is Aug 18, 2026 which is in 38 days.
How were Nano-X Imaging Ltd.’s earnings last quarter?
Nano-X Imaging Ltd. released its earnings results on Jun 25, 2026. The company reported -$0.2 earnings per share for the quarter, missing the consensus estimate of -$0.173 by -$0.027.
Is Nano-X Imaging Ltd. overvalued?
According to Wall Street analysts Nano-X Imaging Ltd.’s price is currently Undervalued.
Does Nano-X Imaging Ltd. pay dividends?
Nano-X Imaging Ltd. does not currently pay dividends.
What is Nano-X Imaging Ltd.’s EPS estimate?
Nano-X Imaging Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nano-X Imaging Ltd. have?
Nano-X Imaging Ltd. has 69,600,784 shares outstanding.
What happened to Nano-X Imaging Ltd.’s price movement after its last earnings report?
Nano-X Imaging Ltd. reported an EPS of -$0.2 in its last earnings report, missing expectations of -$0.173. Following the earnings report the stock price went down -44.013%.
Which hedge fund is a major shareholder of Nano-X Imaging Ltd.?
Currently, no hedge funds are holding shares in NNOX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nano-X Imaging Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.00 (190.70% Upside)
$5.00 (190.70% Upside)
Blogger Sentiment
Bullish
NNOX Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 320.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.4%
Last 30 Days ▲ 6.3%
Last 30 Days ▲ 6.3%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-77.54%
12-Months-Change
Fundamentals
Return on Equity
-47.09%
Trailing 12-Months
Asset Growth
-25.91%
Trailing 12-Months
Company Description
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
NNOX Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mix of operational progress and commercial momentum — including deployments at RadNet, large partner agreements (~360 potential systems), accelerating teleradiology and AI revenues, and cross-division integrations — but these positives are offset by material near-term financial challenges: cash decline, substantial doubt about going concern, continued quarterly cash burn, increased operating losses, withdrawal of 2026 revenue guidance, and timing delays converting agreements into recognized revenue. The tone is cautiously constructive on execution and long-term opportunity but guarded on short-term financial health.View all NNOX earnings summariesNNOX Stock 12 Month Forecast
Average Price Target
$5.00
▲(190.70% Upside)
Technical Analysis
Ownership Overview
0.09% Insiders
2.46% Mutual Funds
0.05% Other Institutional Investors
94.93% Public Companies and
Individual Investors